MSVVX
Price
$14.15
Change
-$0.16 (-1.12%)
Updated
Nov 13 closing price
VSCIX
Price
$120.70
Change
-$0.00 (-0.00%)
Updated
Nov 13 closing price
Ad is loading...

MSVVX vs VSCIX

Header iconMSVVX vs VSCIX Comparison
Open Charts MSVVX vs VSCIXBanner chart's image
Mesirow Small Company Investor
Price$14.15
Change-$0.16 (-1.12%)
VolumeN/A
CapitalizationN/A
Vanguard Small Cap Index I
Price$120.70
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
MSVVX vs VSCIX Comparison Chart
Loading...
View a ticker or compare two or three
VS
MSVVX vs. VSCIX commentary
Nov 14, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MSVVX is a StrongBuy and VSCIX is a StrongBuy.

FUNDAMENTALS
Fundamentals
VSCIX has more cash in the bank: 151B vs. MSVVX (34.1M). VSCIX pays higher dividends than MSVVX: VSCIX (1.43) vs MSVVX (0.49). MSVVX was incepted earlier than VSCIX: MSVVX (6 years) vs VSCIX (27 years). MSVVX is a more actively managed with annual turnover of: 102.00 vs. VSCIX (12.00). MSVVX has a lower initial minimum investment than VSCIX: MSVVX (5000) vs VSCIX (5000000). VSCIX annual gain was more profitable for investors over the last year : 32.13 vs. MSVVX (25.33). VSCIX return over 5 years is better than : 59.15 vs. MSVVX (25.44).
MSVVXVSCIXMSVVX / VSCIX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence6 years27 years-
Gain YTD19.91518.404108%
Front LoadN/AN/A-
Min. Initial Investment500050000000%
Min. Initial Investment IRAN/AN/A-
Net Assets34.1M151B0%
Annual Yield % from dividends0.491.4334%
Returns for 1 year25.3332.1379%
Returns for 3 years-6.757.14-94%
Returns for 5 years25.4459.1543%
Returns for 10 yearsN/A128.63-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PHVS20.150.31
+1.56%
Pharvaris NV
BOX34.670.43
+1.26%
BOX
TSCO278.75-0.44
-0.16%
Tractor Supply Company
XGN2.75-0.04
-1.43%
Exagen
AMTX4.11-0.51
-11.04%
Aemetis